Literature DB >> 9300530

Differential cytosolic tail dependence and intracellular fate of T-cell receptors internalized upon activation with superantigen or phorbol ester.

F Niedergang1, E San José, B Rubin, B Alarcón, A Dautry-Varsat, A Alcover.   

Abstract

Activation of T lymphocytes by T-cell receptor (TCR) ligands such as peptide/MHC complexes, superantigens or anti-TCR mAbs, or by pharmacological activators of protein kinase C such as phorbol esters, results in the internalization and cell surface downregulation of TCRs. We investigated the role of internalization motifs located in the cytosolic region of CD3 gamma in the internalization of TCR complexes induced by enterotoxin superantigens, anti-TCR mAbs or phorbol esters. To this end, a series of CD3 gamma mutants were expressed in a CD3 gamma-deficient variant of the human T-cell line Jurkat. We found that serine126 and the di-leucine motif (Leu131-Leu132) are required for phorbol-ester-induced TCR downregulation, but they are not necessary for enterotoxin superantigen or antibody-induced TCR downregulation. Moreover, the tyrosine-based motifs (residues 138 to 141 and 149 to 152) are not required either for phorbol aster or for superantigen or antibody-induced TCR downregulation. Confocal microscopy analysis reveals that TCR complexes accumulate in an early endocytic/recycling compartment upon activation of cells with phorbol esters, whereas TCRs internalized upon activation with superantigen or anti-TCR mAbs are routed to lysosomes. Consistent with this intracellular localization, TCRs internalized in response to phorbol ester are not degraded and can be reexpressed on the cell surface. In contrast, TCRs internalized upon superantigen activation are degraded.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9300530     DOI: 10.1016/s0923-2494(97)80865-6

Source DB:  PubMed          Journal:  Res Immunol        ISSN: 0923-2494


  4 in total

1.  The transmembrane adaptor protein TRIM regulates T cell receptor (TCR) expression and TCR-mediated signaling via an association with the TCR zeta chain.

Authors:  H Kirchgessner; J Dietrich; J Scherer; P Isomäki; V Korinek; I Hilgert; E Bruyns; A Leo; A P Cope; B Schraven
Journal:  J Exp Med       Date:  2001-06-04       Impact factor: 14.307

2.  Stoichiometry and intracellular fate of TRIM-containing TCR complexes.

Authors:  Mahima Swamy; Gabrielle M Siegers; Gina J Fiala; Eszter Molnar; Elaine P Dopfer; Paul Fisch; Burkhart Schraven; Wolfgang Wa Schamel
Journal:  Cell Commun Signal       Date:  2010-03-18       Impact factor: 5.712

3.  A novel pulse-chase SILAC strategy measures changes in protein decay and synthesis rates induced by perturbation of proteostasis with an Hsp90 inhibitor.

Authors:  Ivo Fierro-Monti; Julien Racle; Celine Hernandez; Patrice Waridel; Vassily Hatzimanikatis; Manfredo Quadroni
Journal:  PLoS One       Date:  2013-11-27       Impact factor: 3.240

4.  Dynamic impacts of the inhibition of the molecular chaperone Hsp90 on the T-cell proteome have implications for anti-cancer therapy.

Authors:  Ivo Fierro-Monti; Pablo Echeverria; Julien Racle; Celine Hernandez; Didier Picard; Manfredo Quadroni
Journal:  PLoS One       Date:  2013-11-27       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.